Oridion Report issue

For profit Phase 3
Founded: Needham MA United States (1987)
Status: Acquired by Covidien (2012) → now Medtronic (2014)

Organization Overview

First Clinical Trial
2005
NCT00244569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

methacetin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 3)

Fibrosis (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1